...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Who owns ZCC Zenith Capital

If the RPS are held by ZCC and dividends are paid to Zenith Epigenitics ZEN, who decides when ZEN shareholders get paid a dividend?

Share
New Message
Please login to post a reply